# Episode 91 - Dr. Tania Dempsey - How GLP-1s Are Transforming MCAS Treatment

Page: https://stenobird.com/podcast/this-healthy-life-7301694/episode-91-dr-tania-dempsey-how-glp-1s-are-transforming-mcas-treatment
Text version: https://stenobird.com/podcast/this-healthy-life-7301694/episode-91-dr-tania-dempsey-how-glp-1s-are-transforming-mcas-treatment.md
Podcast: [This Healthy Life](https://stenobird.com/podcast/this-healthy-life-7301694)
Published: 2026-02-17T15:07:02+00:00
Episode link: https://podcasters.spotify.com/pod/show/this-healthy-life/episodes/Episode-91---Dr--Tania-Dempsey---How-GLP-1s-Are-Transforming-MCAS-Treatment-e3f3gno
Audio file: https://anchor.fm/s/f5a1afb8/podcast/play/115507384/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-1-17%2F418275680-44100-2-3e1dbb9dfd4c4.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/this-healthy-life-7301694/episodes/episode-91-dr-tania-dempsey-how-glp-1s-are-transforming-mcas-treatment
Duration seconds: 2711

## Resource

MEET THE GUEST Dr. Tania Dempsey is a leading expert in Mast Cell Activation Syndrome (MCAS) and complex chronic illness. A board-certified integrative physician, she focuses on uncovering biochemical, immune, and environmental drivers of disease. She is the founder of the AIM Center for Personalized Medicine in New York and works with patients worldwide. WHAT WE TALK ABOUT Dr. Tania's journey from conventional internal medicine to becoming a leading expert in mast cell activation syndrome and complex chronic illness. Why MCAS has become increasingly common, the role of genetics, infections, toxins, and epigenetics, and how long COVID is reshaping our understanding of mast cell disorders. The interconnected nature of chronic symptoms and why treating patients in seven minute visits never works for complex illness. How GLP 1 receptor agonists are emerging as powerful tools for stabilizing mast cells, reducing inflammation, and improving symptoms far beyond weight loss. Findings from her case series showing significant MCAS symptom improvement even at microdoses of semaglutide and tirzepatide. How GLP 1s compare to traditional MCAS treatments like antihistamines, cromolyn, and leukotriene inhibitors, and why they may need to be used earlier in care. The metabolic connection: how mast cells influence insulin resistance, why diet matters, and how approaches like carnivore or low plant toxin diets can calm mast cell activity. The role of the nervous system, limbic retraining, and stress in driving MCAS and why nervous system work is often the first step in stabilization. Personalized treatment: how she chooses between semaglutide, tirzepatide, and other emerging medications, and why dosing must be individualized. Long term use, expectations, and why GLP 1s may become recogn…

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/this-healthy-life-7301694/episodes/episode-91-dr-tania-dempsey-how-glp-1s-are-transforming-mcas-treatment/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/this-healthy-life-7301694/episode-91-dr-tania-dempsey-how-glp-1s-are-transforming-mcas-treatment.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.